Gazzaley A H, Weiland N G, McEwen B S, Morrison J H
Laboratories for Neurobiology of Aging, Fishberg Research Center for Neurobiology, New York, New York 10029-6574, USA.
J Neurosci. 1996 Nov 1;16(21):6830-8. doi: 10.1523/JNEUROSCI.16-21-06830.1996.
Estradiol treatment increases the number of NMDA receptor binding sites, and changes evoked synaptic currents in a manner consistent with a steroid-induced functional enhancement of NMDA receptors in rat hippocampus. In this study, we investigate the cellular mechanisms of estradiol-induced NMDA receptor regulation at the protein and mRNA levels in ovariectomized rats treated with ovarian steroids using immunocytochemical and in situ hybridization techniques. Confocal laser scanning microscopy was used to quantify alterations in immunofluorescence intensity levels of NMDAR1 subunit proteins within neuronal somata and dendrites of discrete hippocampal fields, whereas in parallel, in situ hybridization was used to examine NMDAR1 mRNA levels in corresponding hippocampal regions. The data indicate that estradiol treatment in ovariectomized rats significantly increases immunofluorescence intensity levels in comparison with nonsteroid treated ovariectomized rats within the somata and dendrites of CA1 pyramidal cells and, to a lesser extent, within the granule cell somata of the dentate gyrus. In contrast, such alterations in immunofluorescence intensity occur without concomitant changes in mRNA hybridization levels. Thus, these data suggest that estradiol modulates NMDA receptor function via post-transcriptional regulation of the NMDAR1 subunit protein. The increase in immunofluorescence intensity may reflect an increase in the concentration of the subunit protein, which could account for estrogen-induced changes in pharmacological and physiological properties of the NMDA receptor.
雌二醇治疗可增加NMDA受体结合位点的数量,并以一种与大鼠海马体中类固醇诱导的NMDA受体功能增强相一致的方式改变诱发的突触电流。在本研究中,我们使用免疫细胞化学和原位杂交技术,在接受卵巢类固醇治疗的去卵巢大鼠中,从蛋白质和mRNA水平研究雌二醇诱导的NMDA受体调节的细胞机制。共聚焦激光扫描显微镜用于量化离散海马区神经元胞体和树突内NMDAR1亚基蛋白免疫荧光强度水平的变化,与此同时,原位杂交用于检测相应海马区的NMDAR1 mRNA水平。数据表明,与未接受类固醇治疗的去卵巢大鼠相比,接受雌二醇治疗的去卵巢大鼠CA1锥体细胞的胞体和树突内,以及齿状回颗粒细胞胞体内的免疫荧光强度水平显著增加,齿状回颗粒细胞胞体内的增加程度较小。相比之下,免疫荧光强度的这种变化并未伴随mRNA杂交水平的相应变化。因此,这些数据表明,雌二醇通过对NMDAR1亚基蛋白的转录后调节来调控NMDA受体功能。免疫荧光强度的增加可能反映了亚基蛋白浓度的增加,这可以解释雌激素诱导的NMDA受体药理学和生理学特性的变化。